The effect of vitamin D supplement in subjects with type 2 diabetes mellitus

Phase 4

Recruiting

• Conditions: Type2 diabetes mellitus; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12614000594628
• Lead Sponsor: Ain Shams University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-06-04
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Adult subjects with type 2 diabetes mellitus

Exclusion Criteria

We should exclude any subjects with hepatic, renal malignancy, bone disease, gall bladder disease, and gastrointestinal disease, history of anticonvulsants, calcium, or vitamin D intake for the last 3 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
25(OH) vitamin D level will be evaluated by serum assay.[ Two months after completing taking of 4500 IU/ day of vitamin D oral drops.];Fasting blood glucose will be evaluated by serum assay.[Two months after completing taking of 4500 IU/ day of vitamin D oral drops.];Lipid profile will be evaluated by serum assay. [Two months after completing taking of 4500 IU/ day of vitamin D oral drops.]

Secondary Outcome Measures

Name	Time	Method
nil[nil]